Enhancement of intestinal barrier function and alleviation of mycophenolic acid toxicity by a probiotic-conditioned medium in vitro

益生菌培养基体外增强肠道屏障功能并减轻霉酚酸毒性

阅读:1

Abstract

Immunosuppressant drugs may damage the intestinal barrier (IB) either indirectly by promoting dysbiosis, or directly by cytotoxic effects exerted on intestinal cells. This has been demonstrated, for instance, with the inosine monophosphate inhibitor mycophenolic acid (MPA) and with its ester prodrug mycophenolate mofetil (MMF). These two drugs can cause severe gastrointestinal toxicity in transplant patients receiving them for rejection prophylaxis. We investigated whether a multistrain probiotic preparation could protect against MPA- and MMF-induced IB damage using differentiated CaCo-2 cells as in vitro model. We obtained an acellular probiotic conditioned medium by culturing the multistrain probiotic preparation in DMEM + FBS, either with or without MPA or MMF. The probiotic conditioned medium reduced IB permeability when added to the upper compartment of the transwell both in the presence and in the absence of these immunosuppressant drugs, as indicated by an increase in transepithelial electrical resistance. The probiotic conditioned medium also prevented cytotoxicity induced by both MPA and MMF and increased the expression of the tight junction proteins zonulin-1 and claudin-5, both of which contribute to barrier tightness. The protective effects of the probiotic medium may depend on preventing free radical damage, as we found that it reduced free oxygen radicals in cells exposed to either MPA, MMF or to the pro-oxidant compound tert-butyl hydroperoxide (tBHP). Finally, the probiotic conditioned medium reduced the activity of the ABC1B1 pump, though this did not result in changes in transwell IB crossing by MPA or MMF. In conclusion, we demonstrated that a multistrain probiotic preparation can protect the intestinal barrier from toxicity induced by MPA and MMF. The fact that this was a postbiotic effect, as it occurred in the absence of probiotic microorganisms, could be relevant for immunocompromised patients, as probiotic bacteria could potentially induce opportunistic infections in these subjects.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。